Trial Profile
Planned phase I trial of CALAA 02.
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2011
Price :
$35
*
At a glance
- Drugs CALAA 02 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 18 Sep 2008 New trial record.